Casi PharmaceuticalsCASIF
13F holders, Q3 2025 (September 30)22holders −2
3new positions
5sold out
1famous investor
$1.66avg. 13F price*
At the end of Q3 2025, 22 institutions reported holding Casi Pharmaceuticals Inc. (CASIF) in their 13F filings, down 2 from Q2 2025. 3 opened new positions and 5 sold out. The largest holders were Venrock Adviser, LLC ($1.6M), Foresite Capital Management VI LLC ($1.6M) and Bank of America Corp. ($423K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Casi Pharmaceuticals Inc.
- CUSIP
- G1933S101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $76K |
| Exits | 5 | $121K |
All 13F filers, Q2 2025 → Q3 2025: 486,179 shares bought and 124,385 shares sold, net +361,794 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Venrock Adviser, LLC | 0.09% | No change | 987,259 | $1.6M |
| Foresite Capital Management VI LLC | 0.63% | Add +24.5% | 979,956 | $1.6M |
| Bank of America Corp. | 0.00% | Add +2013.3% | 254,884 | $423K |
| Woodline Partners LP | 0.00% | No change | 165,640 | $275K |
| Wellington Shields Capital Management, LLC | 0.02% | Reduce -23.5% | 69,535 | $115K |
| Renaissance Technologies | 0.00% | Add +12.0% | 43,900 | $73K |
| Two Sigma Investments, LP | 0.00% | New | 33,267 | $55K |
| Wellington Shields & Co., LLC | 0.01% | No change | 30,091 | $50K |
| Geode Capital Management, LLC | 0.00% | No change | 18,808 | $31K |
| Ground Swell Capital, LLC | 0.04% | New | 10,135 | $17K |
| Royal Bank of Canada | 0.00% | No change | 9,950 | $16K |
| Group One Trading LLC | 0.00% | New | 2,300 | $4K |
| Wells Fargo & Company | 0.00% | No change | 505 | $838 |
| Morgan Stanley | 0.00% | No change | 365 | $606 |
| BlackRock, Inc. | 0.00% | No change | 296 | $491 |
| BNP Paribas Financial Markets | 0.00% | No change | 134 | $222 |
| JPMorgan Chase & Co. | 0.00% | No change | 25 | $42 |
| UBS Group AG | 0.00% | Reduce -98.5% | 14 | $23 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 13 | $22 |
| Colonial Trust Co / SC | 0.00% | No change | 11 | $18 |
| MAI Capital Management | 0.00% | No change | 5 | $9 |
| Simplex Trading, LLC | 0.00% | Add +457.7% | 145 | $0 |
"% of holder's portfolio" is CASIF's weight in each manager's 13F, not the share of Casi Pharmaceuticals Inc. the manager owns.